Annual Book Value:
-$1.60B-$1.15B(-251.88%)Summary
- As of today, ESPR annual book value is -$1.60 billion, with the most recent change of -$1.15 billion (-251.88%) on December 31, 2024.
- During the last 3 years, ESPR annual book value has fallen by -$1.40 billion (-712.94%).
- ESPR annual book value is now -657.35% below its all-time high of $287.26 million, reached on December 31, 2015.
Performance
ESPR Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Book Value:
-$451.36M-$17.85M(-4.12%)Summary
- As of today, ESPR quarterly book value is -$451.36 million, with the most recent change of -$17.85 million (-4.12%) on September 30, 2025.
- Over the past year, ESPR quarterly book value has dropped by -$81.15 million (-21.92%).
- ESPR quarterly book value is now -243.55% below its all-time high of $314.43 million, reached on March 31, 2015.
Performance
ESPR Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
ESPR Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -251.9% | -21.9% |
| 3Y3 Years | -712.9% | -53.5% |
| 5Y5 Years | -8125.2% | -5137.5% |
ESPR Book Value Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -712.9% | at low | -53.5% | +0.8% |
| 5Y | 5-Year | -8125.2% | at low | -5137.5% | +0.8% |
| All-Time | All-Time | -657.4% | at low | -243.6% | +0.8% |
ESPR Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -$451.36M(-4.1%) |
| Jun 2025 | - | -$433.51M(-1.7%) |
| Mar 2025 | - | -$426.21M(-9.6%) |
| Dec 2024 | -$1.60B(-251.9%) | -$388.72M(-5.0%) |
| Sep 2024 | - | -$370.21M(-7.6%) |
| Jun 2024 | - | -$344.22M(-17.0%) |
| Mar 2024 | - | -$294.30M(+35.3%) |
| Dec 2023 | -$454.99M(-40.5%) | -$454.99M(-11.0%) |
| Sep 2023 | - | -$410.00M(-10.2%) |
| Jun 2023 | - | -$371.98M(-12.8%) |
| Mar 2023 | - | -$329.66M(-1.8%) |
| Dec 2022 | -$323.78M(-64.4%) | -$323.78M(-10.1%) |
| Sep 2022 | - | -$294.10M(-0.8%) |
| Jun 2022 | - | -$291.70M(-17.1%) |
| Mar 2022 | - | -$249.04M(-26.5%) |
| Dec 2021 | -$196.94M(-104.9%) | -$196.94M(+45.7%) |
| Sep 2021 | - | -$362.70M(-19.2%) |
| Jun 2021 | - | -$304.31M(-13.0%) |
| Mar 2021 | - | -$269.39M(-180.2%) |
| Dec 2020 | -$96.13M(-581.9%) | -$96.13M(-1172.9%) |
| Sep 2020 | - | $8.96M(-89.5%) |
| Jun 2020 | - | $85.49M(+270.1%) |
| Mar 2020 | - | -$50.25M(-351.9%) |
| Dec 2019 | $19.95M(-74.8%) | $19.95M(-70.9%) |
| Sep 2019 | - | $68.51M(-47.0%) |
| Jun 2019 | - | $129.33M(-26.1%) |
| Mar 2019 | - | $175.01M(+121.2%) |
| Dec 2018 | $79.12M | $79.12M(-39.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $131.75M(-25.1%) |
| Jun 2018 | - | $175.92M(-17.8%) |
| Mar 2018 | - | $214.14M(-12.5%) |
| Dec 2017 | $244.69M(+7.0%) | $244.69M(-12.0%) |
| Sep 2017 | - | $278.10M(+80.5%) |
| Jun 2017 | - | $154.11M(-19.9%) |
| Mar 2017 | - | $192.42M(-15.8%) |
| Dec 2016 | $228.60M(-20.4%) | $228.60M(-10.1%) |
| Sep 2016 | - | $254.18M(-5.1%) |
| Jun 2016 | - | $267.96M(-3.5%) |
| Mar 2016 | - | $277.76M(-3.3%) |
| Dec 2015 | $287.26M(+115.1%) | $287.26M(-3.1%) |
| Sep 2015 | - | $296.48M(-2.9%) |
| Jun 2015 | - | $305.46M(-2.9%) |
| Mar 2015 | - | $314.43M(+135.4%) |
| Dec 2014 | $133.55M(+80.3%) | $133.55M(+165.9%) |
| Sep 2014 | - | $50.22M(-14.7%) |
| Jun 2014 | - | $58.91M(-12.1%) |
| Mar 2014 | - | $67.03M(-9.5%) |
| Dec 2013 | $74.09M(+279.1%) | $74.09M(-11.0%) |
| Sep 2013 | - | $83.23M(+259.0%) |
| Jun 2013 | - | -$52.34M(-365.1%) |
| Mar 2013 | - | $19.74M(+147.7%) |
| Dec 2012 | -$41.36M(-37.7%) | -$41.36M |
| Dec 2011 | -$30.03M(-177.5%) | - |
| Dec 2002 | $38.74M(-41.7%) | - |
| Dec 2001 | $66.50M(-1.8%) | - |
| Dec 2000 | $67.69M(+2304.7%) | - |
| Dec 1999 | $2.81M | - |
FAQ
- What is Esperion Therapeutics, Inc. annual book value?
- What is the all-time high annual book value for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. annual book value year-on-year change?
- What is Esperion Therapeutics, Inc. quarterly book value?
- What is the all-time high quarterly book value for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. quarterly book value year-on-year change?
What is Esperion Therapeutics, Inc. annual book value?
The current annual book value of ESPR is -$1.60B
What is the all-time high annual book value for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high annual book value is $287.26M
What is Esperion Therapeutics, Inc. annual book value year-on-year change?
Over the past year, ESPR annual book value has changed by -$1.15B (-251.88%)
What is Esperion Therapeutics, Inc. quarterly book value?
The current quarterly book value of ESPR is -$451.36M
What is the all-time high quarterly book value for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high quarterly book value is $314.43M
What is Esperion Therapeutics, Inc. quarterly book value year-on-year change?
Over the past year, ESPR quarterly book value has changed by -$81.15M (-21.92%)